TY - JOUR
T1 - Acute and Subchronic Toxicity Studies of Aqueous Extract of Desmodium adscendens (Sw) DC
AU - Quaye, Osbourne
AU - Cramer, Precious
AU - Ofosuhene, Mark
AU - Okine, Laud K.N.
AU - Nyarko, Alexander K.
N1 - Publisher Copyright:
© 2017, © The Author(s) 2017.
PY - 2017/10/1
Y1 - 2017/10/1
N2 - Extracts of Desmodium adscendens (Sw) DC are used for the treatment of various diseases but limited toxicological evaluations have been done on the medicinal plant. This study investigates toxicity effects of the leave extract of D adscendens, and the possibility of drug-drug interaction of the plant extract when co-administered with other drugs. Oral administrations of leaf extract of D adscendens to white Wistar rats in an acute toxicity studies allowed the estimation of an LD50 (median lethal dose) value of 1122 mg/kg body weight. In a subchronic toxicity studies, the plant extract caused a decrease in zoxazolamine paralysis time and prevented thiopentone from causing sleep in test animals compared to controls. Overall, the results are consistent with the plant extract being safe at the doses administered in humans. However, the induction of the CYP enzymes is an indication of a possible drug interaction when the plant extract is co-administered with other drugs.
AB - Extracts of Desmodium adscendens (Sw) DC are used for the treatment of various diseases but limited toxicological evaluations have been done on the medicinal plant. This study investigates toxicity effects of the leave extract of D adscendens, and the possibility of drug-drug interaction of the plant extract when co-administered with other drugs. Oral administrations of leaf extract of D adscendens to white Wistar rats in an acute toxicity studies allowed the estimation of an LD50 (median lethal dose) value of 1122 mg/kg body weight. In a subchronic toxicity studies, the plant extract caused a decrease in zoxazolamine paralysis time and prevented thiopentone from causing sleep in test animals compared to controls. Overall, the results are consistent with the plant extract being safe at the doses administered in humans. However, the induction of the CYP enzymes is an indication of a possible drug interaction when the plant extract is co-administered with other drugs.
KW - Desmodium adscendens (Sw) DC
KW - acute toxicity
KW - cytochrome P450 xenobiotic-metabolizing enzymes
KW - drug metabolism
KW - subchronic toxicity
UR - http://www.scopus.com/inward/record.url?scp=85039751267&partnerID=8YFLogxK
U2 - 10.1177/2156587217736587
DO - 10.1177/2156587217736587
M3 - Article
AN - SCOPUS:85039751267
SN - 2156-5872
VL - 22
SP - 753
EP - 759
JO - Journal of Evidence-Based Complementary and Alternative Medicine
JF - Journal of Evidence-Based Complementary and Alternative Medicine
IS - 4
ER -